Pin Therapeutics
PrivateLast Round
Series C
Dec 23, 2024
Est. Valuation
$83.86M
Total Funding Raised
$55.46M
Company Overview
Pin Therapeutics operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series C round in December 2024.
Pin Therapeutics is a biotechnology company that develops therapeutic drugs using targeted protein degradation technology to treat diseases like cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pin Therapeutics Comparables
Compare Pin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyrus Therapeutics | 91% | |
| UPPTHERA | 89% | |
| Ubix Therapeutics | 86% |
For institutional investors. Book with your work email.
Pin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 23, 2024 | ||||
| Debt | Feb 1, 2023 | ||||
| Series B | Feb 21, 2022 | ||||
| Debt | Mar 1, 2021 | ||||
| Series A | Aug 28, 2019 | ||||
Pre Seed | Nov 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Series C |
| CKD Venture Capital | Series C |
| DSC Investment | Debt, Series B, Series C |
| KB Investment | Debt, Series B, Series C |
| Korea Investment Partners | Debt, Series B, Series C |
| KB Investment | Debt, Series B, Series C |
| Company K Partners | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2023
$5.75M debt round completed.
- Mar 1, 2021
Raised $13M from DSC Investment and Honest Ventures.
For institutional investors. Book with your work email.
Pin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pin Therapeutics's valuation, stock price, and market status.
Is Pin Therapeutics a public or private company?
Pin Therapeutics is a private company.
What is the current stock price of Pin Therapeutics?
Pin Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pin Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pin Therapeutics worth (valuation)?
Pin Therapeutics's valuation is estimated at $83.9M based on funding round data.
Can I buy Pin Therapeutics stock?
Pin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pin Therapeutics's last funding round?
Pin Therapeutics's most recent funding round was Series C on December 23, 2024.
Who are the main investors in Pin Therapeutics?
Key investors in Pin Therapeutics include KDB Capital Corp, CKD Venture Capital, DSC Investment, KB Investment, Korea Investment Partners.
Will Pin Therapeutics IPO soon?
No public IPO plans have been announced for Pin Therapeutics.
How can I track Pin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pin Therapeutics's shares on secondary markets.